BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11742564)

  • 1. Carvedilol and vesnarinone: new antiarrhythmic approach in heart failure therapy.
    Cheng JH; Kamiya K; Kodama I
    Acta Pharmacol Sin; 2001 Mar; 22(3):193-200. PubMed ID: 11742564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes.
    Cheng J; Niwa R; Kamiya K; Toyama J; Kodama I
    Eur J Pharmacol; 1999 Jul; 376(1-2):189-201. PubMed ID: 10440104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesnarinone prolongs action potential duration without reverse frequency dependence in rabbit ventricular muscle by blocking the delayed rectifier K+ current.
    Toyama J; Kamiya K; Cheng J; Lee JK; Suzuki R; Kodama I
    Circulation; 1997 Nov; 96(10):3696-703. PubMed ID: 9396473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new antiarrhythmic substance AWD 23-111 inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes.
    Klapperstück M; Markwardt F
    Pharmazie; 1999 Jan; 54(1):61-8. PubMed ID: 9987799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate-dependent effects of sematilide on action potential duration in isolated guinea pig ventricular myocytes.
    Sawanobori T; Adaniya H; Namiki T; Hiraoka M
    J Pharmacol Exp Ther; 1994 Oct; 271(1):302-10. PubMed ID: 7965729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiestrogen tamoxifen blocks the delayed rectifier potassium current, IKr, in rabbit ventricular myocytes.
    Liu XK; Katchman A; Ebert SN; Woosley RL
    J Pharmacol Exp Ther; 1998 Dec; 287(3):877-83. PubMed ID: 9864267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model.
    Courtemanche M; Ramirez RJ; Nattel S
    Cardiovasc Res; 1999 May; 42(2):477-89. PubMed ID: 10533583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beta-adrenergic blocker carvedilol restores L-type calcium current in a myocardial infarction model of rabbit.
    Li X; Huang CX; Jiang H; Cao F; Wang T
    Chin Med J (Engl); 2005 Mar; 118(5):377-82. PubMed ID: 15780206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic effects of carvedilol: is carvedilol an antiarrhythmic agent?
    El-Sherif N; Turitto G
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):985-90. PubMed ID: 16176541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the rapid component of the delayed-rectifier K+ current by therapeutic concentrations of the antispasmodic agent terodiline.
    Jones SE; Ogura T; Shuba LM; McDonald TF
    Br J Pharmacol; 1998 Nov; 125(6):1138-43. PubMed ID: 9863639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular electropharmacology of amiodarone.
    Kodama I; Kamiya K; Toyama J
    Cardiovasc Res; 1997 Jul; 35(1):13-29. PubMed ID: 9302343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of MS-551 and E-4031 on action potentials and the delayed rectifier K+ current in rabbit ventricular myocytes.
    Cheng J; Kamiya K; Kodama I; Toyama J
    Cardiovasc Res; 1996 Jun; 31(6):963-74. PubMed ID: 8759253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes.
    Li BX; Yang BF; Zhou J; Xu CQ; Li YR
    Acta Pharmacol Sin; 2001 Feb; 22(2):125-31. PubMed ID: 11741516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.
    Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological effects of carvedilol on rabbit heart pacemaker cells.
    Yokoyama A; Sato N; Kawamura Y; Hasebe N; Kikuchi K
    Int Heart J; 2007 May; 48(3):347-58. PubMed ID: 17592199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of the antiarrhythmic mechanism of berberine on delayed activation potassium current by voltage clamp].
    Huang WM
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Oct; 20(5):310-2, 325. PubMed ID: 1306830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization.
    Cheng JH; Kodama I
    Acta Pharmacol Sin; 2004 Feb; 25(2):137-45. PubMed ID: 14769199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects of chronic amiodarone therapy and hypothyroidism, alone and in combination, on guinea pig ventricular myocytes.
    Bosch RF; Li GR; Gaspo R; Nattel S
    J Pharmacol Exp Ther; 1999 Apr; 289(1):156-65. PubMed ID: 10086999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of action of class III anti-arrhythmia agents].
    Adamantidis MM
    Arch Mal Coeur Vaiss; 1995 Jan; 88 Spec No 1():33-40. PubMed ID: 7786143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of cardiac potassium channels.
    Li GR; Dong MQ
    Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.